FDA Inspection
Vitalife, Inc.Vitalife, Inc. – FDA Inspection, Aug 25, 2016
Record Details
This FDA Inspection record concerns Vitalife, Inc., with an inspection on August 25, 2016, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Vitalife, Inc.
- Inspection Date
- August 25, 2016
- Product Type
- Biologics
View Company Profile
ID · 924fe65b-94c2-4fde-a46e-57fe5f04178f
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 986131
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
1- 21 CFR 1271.260(e)Storage temperatures recorded, maintained
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Vitalife, Inc.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| May 19, 2022 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| March 9, 2017 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| December 28, 2011 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Vitalife, Inc.
- FDA Inspection 1170934 - 2022-05-19
- FDA Inspection 1007186 - 2017-03-09
- FDA Inspection 760626 - 2011-12-28
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.